Point72 Middle East FZE’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-24,218	Closed	-$425K	–	524
2023 Q4	$425K	Buy	+24,218	New	+$425K	0.01%	424
2023 Q3	–	Sell	-25,669	Closed	-$361K	–	1169
2023 Q2	$361K	Buy	+25,669	New	+$361K	0.01%	472